Loading...

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy

PURPOSE: Immunotherapy has become the standard treatment for advanced tumors so that many biomarkers play parts in predicting prognosis and clinical outcome. Use of FARI is increasing, but there are no studies on its use prior to immunotherapy. PATIENTS AND METHODS: A retrospective study prior to im...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Manag Res
Main Authors: Guo, Ziwei, Liang, Jun
Format: Artigo
Language:Inglês
Published: Dove 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8163584/
https://ncbi.nlm.nih.gov/pubmed/34079370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S307272
Tags: Add Tag
No Tags, Be the first to tag this record!